No, it shouldn't but CytoDyn is not running the GBM trial. It is one of those trials where CytoDyn only has to provide Leronlimab. Albert Einstein Montefiore is running it. They told CytoDyn they would have the results by end of year. So the results will be given to us at their discretion, when they say it’s ready, which should be by end of year